Inhibikase Therapeutics Receives Buy Rating and Increased Price Target from HC Wainwright Co
HC Wainwright & Co. has reiterated its Buy rating for Inhibikase Therapeutics (NASDAQ: IKT) on March 5, 2024, while raising...
HC Wainwright & Co. has reiterated its Buy rating for Inhibikase Therapeutics (NASDAQ: IKT) on March 5, 2024, while raising...
AT&T's stock is experiencing a boost in trading as a result of an upgrade from Wolfe Research on March 5,...
OFS Capital Corporation recently released its financial results for the fourth quarter of 2023, causing a decrease in its stock...
On March 5, 2024, Argo Blockchain disclosed a decline in mining revenue for the month of February, generating $4.5 million....
After analyzing the recent options trading activity for United Parcel Service (UPS), it is evident that big-time investors are taking...
Intrepid Potash (NYSE: IPI) is gearing up to unveil its latest quarterly earnings report on March 6, 2024. Analysts are...
IBM's short interest has seen a significant drop of 8.53% as of March 5, 2024, with 21.61 million shares being...
Ethiopian Airlines has taken a bold step in expanding its fleet by placing an order for up to 20 Boeing...
Williams-Sonoma, Inc.'s CEO, Laura Alber, recently made a significant sale of her shares worth approximately $4 million, catching the attention...
Apple's iPhone sales in China took a sharp nosedive, dropping by 24% in the first six weeks of 2024. Meanwhile,...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.